LJHT
SAGE icon

Laurie J. Hall Trustee’s Sage Therapeutics SAGE Stock Holding History

Laurie J. Hall Trustee’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-55
Closed -$2K – 309
2022
Q4 		$2K Sell
55
-35
-39% -$1.34K ﹤0.01% 288
2022
Q3 		$4K Sell
90
-40
-31% -$1.55K ﹤0.01% 289
2022
Q2 		$4K Hold
130
– – ﹤0.01% 291
2022
Q1 		$4K Hold
130
– – ﹤0.01% 303
2021
Q4 		$6K Hold
130
– – ﹤0.01% 294
2021
Q3 		$6K Buy
130
+50
+63% +$2.29K ﹤0.01% 294
2021
Q2 		$5K Hold
80
– – ﹤0.01% 304
2021
Q1 		$6K Hold
80
– – ﹤0.01% 306
2020
Q4 		$7K Hold
80
– – ﹤0.01% 294
2020
Q3 		$5K Buy
+80
New +$4.05K ﹤0.01% 292

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Laurie J. Hall Trustee's SAGE Position: Q1 2023 in Review

Laurie J. Hall Trustee sold out of Sage Therapeutics (SAGE) in Q1 2023, closing a stake of 55 shares — an estimated $2K sold.

Laurie J. Hall Trustee first reported a position in SAGE in Q3 2020 and held it in 10 quarters. The position peaked at $7K in Q4 2020. 213 funds tracked by Wall St. Rank hold SAGE as of Q1 2023.

  • Laurie J. Hall Trustee reported no remaining Sage Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Laurie J. Hall Trustee sold 55 Sage Therapeutics shares in Q1 2023, an estimated $2K.
  • Laurie J. Hall Trustee first reported a position in Sage Therapeutics in Q3 2020 and held it in 10 quarters.
  • Laurie J. Hall Trustee's Sage Therapeutics position peaked at $7K in Q4 2020.
  • 213 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2023.

Based on Laurie J. Hall Trustee's 13F filing for Q1 2023, filed 7 Apr 2023.